Researching: Pfizer
Pulling real-time news, deal activity, and upcoming catalysts
Analyzing sources for "Pfizer"...
RxInsider Coverage (10)
People
GSK Names First Chief Diversity Officer Amidst Regulatory Challenges and Product Pipeline Expansion: Strategic Implications
Apr 9
Deals
Novartis Spins Off Sandoz: What the $10B Pure-Play Means for Biosimilar Strategies and Drug Pricing 2025-2026
Apr 7
Data
Why Aetna’s 2026 Formulary Drop Hits Eliquis:and What It Means for Anticoagulants
Apr 2
The Week
The Week in Pharma: Lilly Bets $2.5B on Alzheimer’s, Pfizer Shifts Oncology Gears, Policy Upheaval Hits Drug Discovery
Mar 14
The Week
Weekly Pharma Roundup: Merck's $11B Bet, FDA Pushback, and Earnings Surprises
Feb 21
Pipeline
Late-Stage Obesity Drugs Beyond GLP-1s: Orforglipron, Survodutide, and the Oral Alternatives That Could Reshape Pricing
Feb 18
Pipeline
Obesity Pipeline Beyond GLP‑1s: Orforglipron, Survodutide, and the Oral Disruptors
Jan 27
Policy
IRA Price Negotiation Year One: Who Blinked, Who Balked, and What's Next for Big Ticket Drugs
Jan 22
Deals
The Economics of Pharma Mega-Mergers: Why Most Buyers Overpay
Jan 19
Money
Pharma Q2 Earnings: Who Beat on Net Price and Who Got Crushed by GTN
Aug 5
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.